Thonnie Rose See1, Gustav Stålhammar1,2,3, Stephen Phillips1, Hans E Grossniklaus1. 1. Department of Ophthalmology and Pathology, Emory University School of Medicine, Atlanta, Georgia, USA. 2. Oncology and Pathology Service, St. Erik Eye Hospital, Stockholm, Sweden. 3. Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.
Abstract
BACKGROUND: Uveal melanoma (UM) is the most common intraocular tumour in adults. Currently there are different tests available to determine the risk of UM for metastasis, among which include BRCA1-associated protein-1 (BAP1) immunohistochemistry (IHC) and gene expression profiling (GEP). BAP1 is a deubiquitylating enzyme (DUB) that has tumour suppressor activity, the loss of which therefore is associated with higher risk for tumour growth and metastasis. OBJECTIVES: To compare and correlate the prognostic significance of BAP1-IHC staining patterns and GEP in the prediction of UM's risk for metastasis. METHODS: This is a retrospective chart review with prospective follow-up of patients with primary UM who underwent enucleation from the year 2008 to 2018. Clinical history, histopathologic findings, GEP classification, BAP1-IHC of the formalin-fixed paraffin-embedded tissues, and follow-up data for metastasis were collected and statistically analysed. RESULTS: A total of 30 enucleated eyes with UM were included in the study. All class 1a tumours had high nuclear BAP1 expression and all class 2 had low nuclear BAP1 expression. Fifty percent of the class 1b tumours had low nuclear BAP1 expression. Among the tumours with low nuclear BAP1 expression, 68% developed metastasis, while 9% developed metastasis among high nuclear expression. Fifty-five percent developed metastasis in tumours with high cytoplasmic expression and 42% for low cytoplasmic expression. Predictive values for metastasis (positive predictive value, negative predictive value) are as follows: (1) nuclear BAP1-IHC (68%, 91%), (2) cytoplasmic BAP1-IHC (55%, 58%), and (3) GEP (73%, 80%). Nuclear BAP1-IHC and GEP had the same accuracy rate of 77% and cytoplasmic BAP1-IHC had an accuracy of 57%. CONCLUSION: Low nuclear BAP1-IHC strongly correlates with GEP class 2 and was equally accurate in the prediction of metastasis.
BACKGROUND: Uveal melanoma (UM) is the most common intraocular tumour in adults. Currently there are different tests available to determine the risk of UM for metastasis, among which include BRCA1-associated protein-1 (BAP1) immunohistochemistry (IHC) and gene expression profiling (GEP). BAP1 is a deubiquitylating enzyme (DUB) that has tumour suppressor activity, the loss of which therefore is associated with higher risk for tumour growth and metastasis. OBJECTIVES: To compare and correlate the prognostic significance of BAP1-IHC staining patterns and GEP in the prediction of UM's risk for metastasis. METHODS: This is a retrospective chart review with prospective follow-up of patients with primary UM who underwent enucleation from the year 2008 to 2018. Clinical history, histopathologic findings, GEP classification, BAP1-IHC of the formalin-fixed paraffin-embedded tissues, and follow-up data for metastasis were collected and statistically analysed. RESULTS: A total of 30 enucleated eyes with UM were included in the study. All class 1a tumours had high nuclear BAP1 expression and all class 2 had low nuclear BAP1 expression. Fifty percent of the class 1b tumours had low nuclear BAP1 expression. Among the tumours with low nuclear BAP1 expression, 68% developed metastasis, while 9% developed metastasis among high nuclear expression. Fifty-five percent developed metastasis in tumours with high cytoplasmic expression and 42% for low cytoplasmic expression. Predictive values for metastasis (positive predictive value, negative predictive value) are as follows: (1) nuclear BAP1-IHC (68%, 91%), (2) cytoplasmic BAP1-IHC (55%, 58%), and (3) GEP (73%, 80%). Nuclear BAP1-IHC and GEP had the same accuracy rate of 77% and cytoplasmic BAP1-IHC had an accuracy of 57%. CONCLUSION: Low nuclear BAP1-IHC strongly correlates with GEP class 2 and was equally accurate in the prediction of metastasis.
Authors: D E Jensen; M Proctor; S T Marquis; H P Gardner; S I Ha; L A Chodosh; A M Ishov; N Tommerup; H Vissing; Y Sekido; J Minna; A Borodovsky; D C Schultz; K D Wilkinson; G G Maul; N Barlev; S L Berger; G C Prendergast; F J Rauscher Journal: Oncogene Date: 1998-03-05 Impact factor: 9.867
Authors: J William Harbour; Michael D Onken; Elisha D O Roberson; Shenghui Duan; Li Cao; Lori A Worley; M Laurin Council; Katie A Matatall; Cynthia Helms; Anne M Bowcock Journal: Science Date: 2010-11-04 Impact factor: 47.728
Authors: Johannes A P van de Nes; Jasmin Nelles; Stefan Kreis; Claudia H D Metz; Thomas Hager; Dietmar R Lohmann; Michael Zeschnigk Journal: Am J Surg Pathol Date: 2016-06 Impact factor: 6.394
Authors: Klaus G Griewank; Johannes van de Nes; Bastian Schilling; Iris Moll; Antje Sucker; Hojabr Kakavand; Lauren E Haydu; Marina Asher; Lisa Zimmer; Uwe Hillen; John F Thompson; Richard A Scolyer; Dirk Schadendorf; Rajmohan Murali Journal: Mod Pathol Date: 2013-07-26 Impact factor: 7.842
Authors: Silvin Bakalian; Jean-Claude Marshall; Patrick Logan; Dana Faingold; Shawn Maloney; Sebastian Di Cesare; Claudia Martins; Bruno F Fernandes; Miguel N Burnier Journal: Clin Cancer Res Date: 2008-02-15 Impact factor: 12.531
Authors: Katie A Matatall; Olga A Agapova; Michael D Onken; Lori A Worley; Anne M Bowcock; J William Harbour Journal: BMC Cancer Date: 2013-08-05 Impact factor: 4.430
Authors: Mathieu F Bakhoum; Jasmine H Francis; Albert Agustinus; Ethan M Earlie; Melody Di Bona; David H Abramson; Mercedes Duran; Ignas Masilionis; Elsa Molina; Alexander N Shoushtari; Michael H Goldbaum; Paul S Mischel; Samuel F Bakhoum; Ashley M Laughney Journal: Nat Commun Date: 2021-09-13 Impact factor: 17.694
Authors: Christina Herrspiegel; Anders Kvanta; Emma Lardner; Louise Ramsköld Cabaca; Jill Wells; Katarina Bartuma; Stefan Seregard; Gustav Stålhammar Journal: Br J Ophthalmol Date: 2020-06-10 Impact factor: 4.638
Authors: Yasemin C Cole; Yu-Zhi Zhang; Beatrice Gallo; Adam P Januszewski; Anca Nastase; David J Essex; Caroline M H Thaung; Victoria M L Cohen; Mandeep S Sagoo; Anne M Bowcock Journal: Cancers (Basel) Date: 2022-08-25 Impact factor: 6.575